Loading insider details...
Latest Form 4 (Sep 10, 2026): Sale of 500 LYEL shares, $6.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Lyell Immunopharma, Inc. (LYEL) | Sale | 500 | $6.3K |
| Jun 11, 2026 | Lyell Immunopharma, Inc. (LYEL) | Sale | 1,977 | $25.0K |
| Feb 12, 2026 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 50,000 | n/a |
| Jun 11, 2025 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 21,900 | n/a |
| Jan 17, 2025 | Nkarta, Inc. (NKTX) | Sale | 8,638 | $19.0K |
| Jan 7, 2025 | Nkarta, Inc. (NKTX) | Grant/Award | 59,000 | n/a |
| Aug 23, 2024 | Nkarta, Inc. (NKTX) | Grant/Award | 1,352 | $6.9K |
| Jul 31, 2024 | Nkarta, Inc. (NKTX) | Grant/Award | 23,421 | n/a |
| Jun 20, 2024 | Nkarta, Inc. (NKTX) | Sale | 456 | $2.6K |
| Jan 18, 2024 | Nkarta, Inc. (NKTX) | Sale | 3,552 | $31.0K |